AR102215A1 - COMPOSITE OF PIRAZOL-4-CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents

COMPOSITE OF PIRAZOL-4-CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Info

Publication number
AR102215A1
AR102215A1 ARP150103254A ARP150103254A AR102215A1 AR 102215 A1 AR102215 A1 AR 102215A1 AR P150103254 A ARP150103254 A AR P150103254A AR P150103254 A ARP150103254 A AR P150103254A AR 102215 A1 AR102215 A1 AR 102215A1
Authority
AR
Argentina
Prior art keywords
carboxamide
pirazol
composite
manufacture
pharmaceutical composition
Prior art date
Application number
ARP150103254A
Other languages
Spanish (es)
Inventor
Marie Kessler Albane
Vincent Hughes Terry
Elban Mark
Cotillo Torrejon Ignacio
Kenneth Charnley Adam
Alonso Padilla Julio
Anne Knapp-Reed Beth
Lian Yiqian
Julio Martin Jose
Pea Urquiza Imanol
Rodriguez Ana
Original Assignee
Glaxosmithkline Ip Dev Ltd
New York Univ School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd, New York Univ School Of Medicine filed Critical Glaxosmithkline Ip Dev Ltd
Publication of AR102215A1 publication Critical patent/AR102215A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El compuesto 3-(benzo[d]tiazol-5-il)-5-(metilamino)-1-(2,2,2,-trifluoroetil)-1H-pirazol-4-carboxamida, que tiene la fórmula (1), o una de sus sales, composiciones que comprenden el compuesto, y su uso en el tratamiento o la prevención de la enfermedad de Chagas.The compound 3- (benzo [d] thiazol-5-yl) -5- (methylamino) -1- (2,2,2, -trifluoroethyl) -1H-pyrazol-4-carboxamide, having the formula (1) , or one of its salts, compositions comprising the compound, and its use in the treatment or prevention of Chagas disease.

ARP150103254A 2014-10-10 2015-10-08 COMPOSITE OF PIRAZOL-4-CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AR102215A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14382386 2014-10-10

Publications (1)

Publication Number Publication Date
AR102215A1 true AR102215A1 (en) 2017-02-15

Family

ID=51790658

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103254A AR102215A1 (en) 2014-10-10 2015-10-08 COMPOSITE OF PIRAZOL-4-CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Country Status (3)

Country Link
AR (1) AR102215A1 (en)
UY (1) UY36350A (en)
WO (1) WO2016055607A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions

Also Published As

Publication number Publication date
WO2016055607A1 (en) 2016-04-14
UY36350A (en) 2016-06-01

Similar Documents

Publication Publication Date Title
CL2018003135A1 (en) Aromatic derivatives of sulfonamide.
DOP2017000109A (en) DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
CL2016001889A1 (en) (2s) -n - [(1s) -1-cyano-2-phenylethyl] -1,4-oxazepan-2-carboxamides as dipeptidyl peptidase 1 inhibitors.
ECSP20025899A (en) COMPOUNDS USEFUL TO INHIBIT CDK7
CL2012003415A1 (en) Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CL2013001338A1 (en) Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
CL2013003019A1 (en) Compounds derived from benzothiazole; pharmaceutical composition that includes them; and its use in the treatment of hiv.
CL2015002698A1 (en) New compounds and compositions for the inhibition of fasn
CL2016001587A1 (en) Derivative based on 1,2-naphthoquinone and method of preparation thereof.
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
CR20160433A (en) NEW COMPOUNDS
CL2016000568A1 (en) Compounds derived from substituted 2h-indazol-2-yl-n-hydroxy-2-methylsulfonyl-2-methyl-butanamide or salts thereof; its pharmaceutical compositions containing them and their use for the prevention and / or treatment of gram-negative bacterial infections.
DOP2016000212A (en) CONDENSED HETEROCICLES REPLACED AS MODULATORS OF GPR119 FOR THE TREATMENT OF DIABETES, OBESITY, DISLIPIDEMIA AND RELATED DISORDERS
AR094707A1 (en) COMPOUND OF QUINAZOLIN-4-AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE TREATMENT OF A DISEASE MEDIATED BY THE RIP2 KINASE
CL2018001590A1 (en) Pharmaceutical compositions comprising some phenylaminopyrimidine derivative.
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
UY36117A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS DISEASES.
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
DOP2016000251A (en) WNT SIGNALING ROAD INHIBITORS
CL2019001618A1 (en) Use of carbamate compounds for prevention, relief or treatment of bipolar disorder.
CL2017002229A1 (en) Bace1 inhibitors.
CO2017001076A2 (en) Antihyperalgesic, anti-allodinic and anti-inflammatory pharmaceutical compositions containing pregabalin and meloxicam
CO2019007671A2 (en) A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of Alzheimer's disease
DOP2016000325A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

Legal Events

Date Code Title Description
FB Suspension of granting procedure